Millennium Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $226K | Sell |
46,332
-8,275
| -15% | -$46.3K | ﹤0.01% | 5129 |
|
|
2025
Q4 | $365K | Sell |
54,607
-2,563
| -4% | -$15.2K | ﹤0.01% | 5138 |
|
|
2025
Q3 | $251K | Sell |
57,170
-6,817
| -11% | -$32.3K | ﹤0.01% | 5431 |
|
|
2025
Q2 | $284K | Buy |
+63,987
| New | +$267K | ﹤0.01% | 5223 |
|
|
2024
Q4 | – | Sell |
-1,195
| Closed | -$32.2K | – | 6211 |
|
|
2024
Q3 | $32.2K | Sell |
1,195
-13,647
| -92% | -$402K | ﹤0.01% | 5744 |
|
|
2024
Q2 | $423K | Buy |
14,842
+12,945
| +682% | +$454K | ﹤0.01% | 4700 |
|
|
2024
Q1 | $80.4K | Sell |
1,897
-4,391
| -70% | -$197K | ﹤0.01% | 5616 |
|
|
2023
Q4 | $336K | Sell |
6,288
-27,659
| -81% | -$1.25M | ﹤0.01% | 4907 |
|
|
2023
Q3 | $1.46M | Buy |
33,947
+7,382
| +28% | +$341K | ﹤0.01% | 3871 |
|
|
2023
Q2 | $1.46M | Buy |
26,565
+13,227
| +99% | +$726K | ﹤0.01% | 3738 |
|
|
2023
Q1 | $560K | Sell |
13,338
-3,085
| -19% | -$91.5K | ﹤0.01% | 4531 |
|
|
2022
Q4 | $455K | Sell |
16,423
-4,148
| -20% | -$102K | ﹤0.01% | 4811 |
|
|
2022
Q3 | $527K | Sell |
20,571
-18,526
| -47% | -$613K | ﹤0.01% | 4931 |
|
|
2022
Q2 | $1.41M | Buy |
39,097
+31,442
| +411% | +$1.42M | ﹤0.01% | 4048 |
|
|
2022
Q1 | $475K | Sell |
7,655
-1,680
| -18% | -$99.4K | ﹤0.01% | 5165 |
|
|
2021
Q4 | $658K | Sell |
9,335
-4,790
| -34% | -$341K | ﹤0.01% | 4799 |
|
|
2021
Q3 | $986K | Sell |
14,125
-431
| -3% | -$34.3K | ﹤0.01% | 4701 |
|
|
2021
Q2 | $1.21M | Buy |
14,556
+8,606
| +145% | +$609K | ﹤0.01% | 4493 |
|
|
2021
Q1 | $325K | Buy |
5,950
+4,252
| +250% | +$207K | ﹤0.01% | 5158 |
|
|
2020
Q4 | $73K | Sell |
1,698
-3,514
| -67% | -$131K | ﹤0.01% | 5059 |
|
|
2020
Q3 | $157 | Buy |
5,212
+329
| +7% | +$11.1K | ﹤0.01% | 4134 |
|
|
2020
Q2 | $151K | Sell |
4,883
-48,640
| -91% | -$1.31M | ﹤0.01% | 3913 |
|
|
2020
Q1 | $1.18M | Buy |
53,523
+2,571
| +5% | +$69.7K | ﹤0.01% | 2360 |
|
|
2019
Q4 | $1.55M | Sell |
50,952
-13,581
| -21% | -$391K | ﹤0.01% | 2764 |
|
|
2019
Q3 | $1.98M | Sell |
64,533
-42,201
| -40% | -$1.05M | ﹤0.01% | 2447 |
|
|
2019
Q2 | $2.13M | Buy |
106,734
+99,210
| +1,319% | +$2.91M | ﹤0.01% | 2367 |
|
|
2019
Q1 | $324K | Buy |
7,524
+5,717
| +316% | +$207K | ﹤0.01% | 3506 |
|
|
2018
Q4 | $57K | Sell |
1,807
-10,136
| -85% | -$400K | ﹤0.01% | 3602 |
|
|
2018
Q3 | $627K | Buy |
11,943
+5,908
| +98% | +$332K | ﹤0.01% | 3119 |
|
|
2018
Q2 | $323K | Sell |
6,035
-16,527
| -73% | -$847K | ﹤0.01% | 3355 |
|
|
2018
Q1 | $1.13M | Buy |
22,562
+20,416
| +951% | +$915K | ﹤0.01% | 2628 |
|
|
2017
Q4 | $71K | Sell |
2,146
-3,277
| -60% | -$111K | ﹤0.01% | 3700 |
|
|
2017
Q3 | $203K | Buy |
+5,423
| New | +$160K | ﹤0.01% | 3240 |
|
|
2017
Q2 | – | Sell |
-1,644
| Closed | -$43K | – | 3618 |
|
|
2017
Q1 | $43K | Sell |
1,644
-1,253
| -43% | -$36.1K | ﹤0.01% | 3397 |
|
|
2016
Q4 | $88K | Sell |
2,897
-1,713
| -37% | -$43.6K | ﹤0.01% | 3209 |
|
|
2016
Q3 | $125K | Sell |
4,610
-15,581
| -77% | -$433K | ﹤0.01% | 3088 |
|
|
2016
Q2 | $577K | Buy |
20,191
+18,533
| +1,118% | +$589K | ﹤0.01% | 2421 |
|
|
2016
Q1 | $50K | Buy |
1,658
+484
| +41% | +$13.7K | ﹤0.01% | 3151 |
|
|
2015
Q4 | $41K | Buy |
+1,174
| New | +$40.2K | ﹤0.01% | 3320 |
|
|
2015
Q2 | – | Sell |
-2,320
| Closed | -$135K | – | 3539 |
|
|
2015
Q1 | $135K | Sell |
2,320
-690
| -23% | -$37.1K | ﹤0.01% | 3370 |
|
|
2014
Q4 | $171K | Sell |
3,010
-197
| -6% | -$9.39K | ﹤0.01% | 3675 |
|
|
2014
Q3 | $131K | Sell |
3,207
-864
| -21% | -$39.7K | ﹤0.01% | 3506 |
|
|
2014
Q2 | $185K | Buy |
+4,071
| New | +$171K | ﹤0.01% | 3153 |
|
|
2014
Q1 | – | Sell |
-1,294
| Closed | -$61K | – | 3648 |
|
|
2013
Q4 | $61K | Sell |
1,294
-1,995
| -61% | -$87.1K | ﹤0.01% | 3375 |
|
|
2013
Q3 | $131K | Buy |
+3,289
| New | +$129K | ﹤0.01% | 3169 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
